Partial purification and pharmacology of peripheral-type benzodiazepine receptors.
This report describes the results obtained with a new photoaffinity ligand for the "peripheral-type" benzodiazepine binding site (PBS), using a digitonin solubilized preparation from rat heart or adrenals. The specific binding activity of the solubilized adrenal preparation is higher than 50 pmol/mg protein, with binding properties and pharmacological specificity identical to the membrane bound PBS. The apparent molecular weight of the solubilized PBS, determined by gel filtration is 215 KDa. The photoaffinity ligand (PK 14105) is a nitrophenyl derivative of PK 11195, which attaches covalently and specifically to all the PBS when cardiac membranes are irradiated with this compound under ultraviolet light. After photolabelling with [3H]PK 14105 and solubilization in SDS of heart or adrenal membranes, gel electrophoresis indicates the existence of a single protein band whose molecular weight (18 KDa) is unaltered by incubation with sulphydryl-reducing or protein cross-linking agents. This molecule seems to be a low molecular weight, acidic protein. Diethylpyrocarbonate decreases partially (60%) the binding of [3H]PK 11195 without affecting [3H] RO5-4864 binding, which implies a vital histidine residue in the binding domain of [3H]-PK 11195. Treatment with phospholipase A2 or mellitin, a stimulant of endogenous PLA2, led to a selective loss of [3H] RO5-4864 binding with no change in the binding of [3H]PK 11195. Such differences between a benzodiazepine ligand and an isoquinoline ligand suggest that these compounds may induce, on binding, different conformational changes in the PBS, which is compatible with the hypothesis that RO5-4864 and PK 11195 may be an agonist and an antagonist respectively at the PBS.
D000311:Adrenal Glands / Q000032:analysis*; D000345:Affinity Labels / Q000378:metabolism*; D000818:Animals; D001569:Benzodiazepines / Q000378:metabolism*; D002846:Chromatography, Affinity; D007525:Isoelectric Focusing; D007546:Isoquinolines / Q000378:metabolism*; D007700:Kinetics; D008970:Molecular Weight; D009206:Myocardium / Q000032:analysis*; D011485:Protein Binding; D051381:Rats; D011963:Receptors, GABA-A / Q000302:isolation & purification* / Q000378:metabolism; D013329:Structure-Activity Relationship
D000345:Affinity Labels; D007546:Isoquinolines; D011963:Receptors, GABA-A; D001569:Benzodiazepines; C051238:PK 14105